We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Bird Rock Bio announced the Company has filed an investigational new drug (IND) application with the U.S. Food and Drug Administration (FDA) for the initiation of a phase 2 clinical study of nimacimab, also known as RYI-018 ...
The Lutonix drug-coated balloon is now FDA-approved to treat stenosis in the AV fistulae of renal disease patients, which can reduce the number of reinterventions they need to keep up their dialysis treatments.